FDA Issues Breast Implant Safety Communication

The FDA is informing the public about reports of cancers, including squamous cell carcinoma (SCC) and various lymphomas, that have developed in the scar tissue (capsule) that forms around breast implants. The various lymphomas reported are not the same as the lymphomas described in the previous FDA Communications as Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). While the FDA believes that occurrences of SCC or various lymphomas in the capsule around the breast implants may be rare, health care providers and people who have or are considering breast implants should be aware of the issue, and report cases to the FDA.

FDA Safety Communication ⭢

View News Archive